Literature DB >> 20434526

Emerging roles of PDGF-D signaling pathway in tumor development and progression.

Zhiwei Wang1, Aamir Ahmad, Yiwei Li, Dejuan Kong, Asfar S Azmi, Sanjeev Banerjee, Fazlul H Sarkar.   

Abstract

Platelet-derived growth factor-D (PDGF-D) can regulate many cellular processes, including cell proliferation, apoptosis, transformation, migration, invasion, angiogenesis and metastasis. Therefore PDGF-D signaling has been considered to be important in human malignancies, and thus PDGF-D signaling may represent a novel therapeutic target, and as such suggests that the development of agents that will target PDGF-D signaling is likely to have a significant therapeutic impact on human cancers. This mini-review describes the mechanisms of signal transduction associated with PDGF-D signaling to support the role of PDGF-D in the carcinogenesis. Moreover, we summarize data on several PDGF-D inhibitors especially naturally occurring "chemopreventive agent" such an indole compound, which we believe could serve as a novel agent for the prevention of tumor progression and/or treatment of human malignancies by targeted inactivation of PDGF-D signaling. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20434526      PMCID: PMC2885511          DOI: 10.1016/j.bbcan.2010.04.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  72 in total

Review 1.  The PDGF family: four gene products form five dimeric isoforms.

Authors:  Linda Fredriksson; Hong Li; Ulf Eriksson
Journal:  Cytokine Growth Factor Rev       Date:  2004-08       Impact factor: 7.638

Review 2.  Notch signaling.

Authors:  Lucio Miele
Journal:  Clin Cancer Res       Date:  2006-02-15       Impact factor: 12.531

Review 3.  Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.

Authors:  Roopali Roy; Jiang Yang; Marsha A Moses
Journal:  J Clin Oncol       Date:  2009-09-08       Impact factor: 44.544

Review 4.  PDGF-D signaling: a novel target in cancer therapy.

Authors:  Zhiwei Wang; Dejuan Kong; Yiwei Li; Fazlul H Sarkar
Journal:  Curr Drug Targets       Date:  2009-01       Impact factor: 3.465

Review 5.  Signaling mechanism(s) of reactive oxygen species in Epithelial-Mesenchymal Transition reminiscent of cancer stem cells in tumor progression.

Authors:  Zhiwei Wang; Yiwei Li; Fazlul H Sarkar
Journal:  Curr Stem Cell Res Ther       Date:  2010-03       Impact factor: 3.828

Review 6.  NF-kappaB signaling pathway and its therapeutic implications in human diseases.

Authors:  Fazlul H Sarkar; Yiwei Li; Zhiwei Wang; Dejuan Kong
Journal:  Int Rev Immunol       Date:  2008       Impact factor: 5.311

7.  Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase pathway in human schwannoma.

Authors:  Sylwia Ammoun; Christine Flaiz; Natalia Ristic; Jennifer Schuldt; C Oliver Hanemann
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

Review 8.  Focus on molecules: platelet-derived growth factor C, PDGF-C.

Authors:  Hetian Lei; Andrius Kazlauskas
Journal:  Exp Eye Res       Date:  2007-08-19       Impact factor: 3.467

9.  Imatinib mesylate enhances therapeutic effects of gemcitabine in human malignant mesothelioma xenografts.

Authors:  Pietro Bertino; Federica Piccardi; Camillo Porta; Roberto Favoni; Michele Cilli; Luciano Mutti; Giovanni Gaudino
Journal:  Clin Cancer Res       Date:  2008-01-15       Impact factor: 12.531

10.  miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells.

Authors:  Dejuan Kong; Yiwei Li; Zhiwei Wang; Sanjeev Banerjee; Aamir Ahmad; Hyeong-Reh Choi Kim; Fazlul H Sarkar
Journal:  Stem Cells       Date:  2009-08       Impact factor: 6.277

View more
  53 in total

1.  Differential tumorigenic potential and matriptase activation between PDGF B versus PDGF D in prostate cancer.

Authors:  Abdo J Najy; Joshua J Won; Lisa S Movilla; Hyeong-Reh C Kim
Journal:  Mol Cancer Res       Date:  2012-06-11       Impact factor: 5.852

Review 2.  The two faces of FBW7 in cancer drug resistance.

Authors:  Zhiwei Wang; Hidefumi Fukushima; Daming Gao; Hiroyuki Inuzuka; Lixin Wan; Alan W Lau; Pengda Liu; Wenyi Wei
Journal:  Bioessays       Date:  2011-08-30       Impact factor: 4.345

3.  Activated K-Ras and INK4a/Arf deficiency promote aggressiveness of pancreatic cancer by induction of EMT consistent with cancer stem cell phenotype.

Authors:  Zhiwei Wang; Shadan Ali; Sanjeev Banerjee; Bin Bao; Yiwei Li; Asfar S Azmi; Murray Korc; Fazlul H Sarkar
Journal:  J Cell Physiol       Date:  2013-03       Impact factor: 6.384

4.  BMP-4 expression has prognostic significance in advanced serous ovarian carcinoma and is affected by cisplatin in OVCAR-3 cells.

Authors:  Liisa Laatio; Päivi Myllynen; Raisa Serpi; Jaana Rysä; Mika Ilves; Elisa Lappi-Blanco; Heikki Ruskoaho; Kirsi Vähäkangas; Ulla Puistola
Journal:  Tumour Biol       Date:  2011-06-15

5.  Gastric cancer-derived MSC-secreted PDGF-DD promotes gastric cancer progression.

Authors:  Feng Huang; Mei Wang; Tingting Yang; Jie Cai; Qiang Zhang; Zixuan Sun; Xiaodan Wu; Xu Zhang; Wei Zhu; Hui Qian; Wenrong Xu
Journal:  J Cancer Res Clin Oncol       Date:  2014-06-18       Impact factor: 4.553

6.  Cediranib inhibits both the intraosseous growth of PDGF D-positive prostate cancer cells and the associated bone reaction.

Authors:  Abdo J Najy; Young Suk Jung; Joshua J Won; M Katie Conley-LaComb; Allen Saliganan; Chong Jai Kim; Elisabeth Heath; Michael L Cher; R Daniel Bonfil; Hyeong-Reh Choi Kim
Journal:  Prostate       Date:  2011-12-27       Impact factor: 4.104

7.  Molecular markers of epithelial-to-mesenchymal transition are associated with tumor aggressiveness in breast carcinoma.

Authors:  Seema Sethi; Fazlul H Sarkar; Quratulain Ahmed; Sudeshna Bandyopadhyay; Zeina A Nahleh; Assaad Semaan; Wael Sakr; Adnan Munkarah; Rouba Ali-Fehmi
Journal:  Transl Oncol       Date:  2011-08-01       Impact factor: 4.243

8.  Platelet-derived growth factor-D promotes fibrogenesis of cardiac fibroblasts.

Authors:  Tieqiang Zhao; Wenyuan Zhao; Yuanjian Chen; Victoria S Li; Weixin Meng; Yao Sun
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-12       Impact factor: 4.733

Review 9.  Tumor stroma as targets for cancer therapy.

Authors:  Jing Zhang; Jinsong Liu
Journal:  Pharmacol Ther       Date:  2012-10-12       Impact factor: 12.310

Review 10.  An evolving role for DEPTOR in tumor development and progression.

Authors:  Zhiwei Wang; Jiateng Zhong; Hiroyuki Inuzuka; Daming Gao; Shavali Shaik; Fazlul H Sarkar; Wenyi Wei
Journal:  Neoplasia       Date:  2012-05       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.